Table 1. Demographic and clinical sample characteristics.
| Characteristics | OCD (n=41) | HC (n=42) | P-value |
|---|---|---|---|
| n (%) or Mean±s.d. (range) | n (%) or Mean±s.d. (range) | ||
| Female | 27 (65.9%) | 24 (57.1%) | P=0.42 |
| Age (Years) | 32.5±10.0 (20–63) | 31.8±8.3 (20–57) | P=0.73 |
| Age of onset | 15.9±6.40 | — | |
| Disease duration | 16.8±10.6 | — | |
| Y-BOCS total | 22.0±5.4 (15–36) | — | |
| Obsession | 11.4±3.2 (4–17) | — | |
| Compulsions | 10.6±3.5 (0–19) | — | |
| OCI-R total | 25.2±9.2 (9–47) | — | |
| Hoarding | 2.6±2.9 (0–11) | — | |
| Checking | 5.9±3.2 (1–12) | — | |
| Ordering | 3.5±3.7 (0–12) | — | |
| Neutralizing | 1.9±2.6 (0–10) | — | |
| Washing | 4.6±3.7 (0–11) | — | |
| Obsessing | 6.8±3.0 (1–12) | — | |
| BDI | 18.1±11.4 (0–53) | — | |
| Comorbidities | 22 (53.7%) | — | |
| Depression | 12 (29.3%) | — | |
| Anxiety | 3 (7.3%) | — | |
| Depression and anxiety | 3 (7.3%) | — | |
| Personality disorder | 1 (2.4%) | — | |
| Eating disorder | 1 (2.4%) | — | |
| Depression, anxiety, ADHD | 1 (2.4%) | — | |
| Depression, eating disorder, personality disorder | 1 (2.4%) | — | |
| Medication | 29 (70.7%) | — | |
| SSRI | 16 (55.2%) | — | |
| TCA | 4 (13.8%) | — | |
| SSRI+antipsychotic | 3 (10.3%) | — | |
| SSRNI | 2 (6.9%) | — | |
| SSRI+methylphenidate | 1 (3.4%) | — | |
| SSNRI+methylphenidate | 1 (3.4%) | — | |
| NDRI+SSNRI | 1 (3.4%) | — | |
| Benzodiazepine+antipsychotic | 1 (3.4%) | — |
Abbreviations: ADHD, attention deficit hyperactivity disorder; BDI, Beck Depression Inventory; HC, healthy controls; NDRI, norepinephrine-dopamine reuptake inhibitor; OCD, obsessive-compulsive disorder; OCI-R, Obsession-Compulsion Inventory revisited; SSNRI, selective serotonin–norepinephrine reuptake inhibitor; SSRI, selective serotonin reuptake inhibitor; TCA, tricyclic antidepressant; Y-BOCS, Yale-Brown Obsessive-Compulsive Scale.